https://orcid.org/0000-0003-0128-3463
References
- Kobayashi S, Yamamoto T, Yoshiga Y, Okamura T, Kawano R, Yano M. Stabilizing tetrameric structure of ryanodine receptor cures lethal arrhythmia in heart failure. Circ Arrhythm Electrophysiol 2022;15:e011220.
- Nakamura Y, Yamamoto T, Xu X, Kobayashi S, Tanaka S, Tamitani M, et al. Enhancing calmodulin binding to ryanodine receptor is crucial to limit neuronal cell loss in Alzheimer disease. Sci Rep 2021;11:7289.
- Tamitani M, Yamamoto T, Yamamoto N, Fujisawa K, Tanaka S, Nakamura Y, et al. Dantrolene prevents hepatic steatosis by reducing cytoplasmic Ca2+ level and ER stress. Biochem Biophys Rep 2020;23:100787.
- Nawata T, Sakai H, Honda T, Otsuka M, Fujita H, Uchinoumi H, et al. Dantrolene, a stabilizer of the ryanodine receptor, prevents collagen-induced arthritis. Biochem Biophys Res Commun 2022;624:141–5.
- Osipchuk NC, Soulika AM, Fomina AF. Modulation of ryanodine receptors activity alters the course of experimental autoimmune encephalomyelitis in mice. Front Physiol 2021;12:770820.
- Kobayashi S, Wakeyama T, Ono S, Ikeda Y, Omura M, Oda T, et al. A multicenter, randomized, double-blind, controlled study to evaluate the efficacy and safety of dantrolene on ventricular arrhythmia as well as mortality and morbidity in patients with chronic heart failure (SHO-IN trial): rationale and design. J Cardiol 2020;75:454–61.